About Sperm acrosome membrane-associated protein 6
Sperm acrosome membrane-associated protein 6 (SPACA6) is a protein
from Homo sapiens identified by UniProt accession
W5XKT8, 324 residues long.
MolForge cross-references it against 0 known binders and
101 disease associations.
Target properties
| Protein name | Sperm acrosome membrane-associated protein 6 |
| UniProt accession | W5XKT8 |
| Gene | SPACA6 |
| Organism | Homo sapiens |
| Length | 324 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (101)
Diseases linked to this target (Open Targets).
- Genetic chronic primary adrenal insufficiency · score 0.26
- monocyte count · score 0.22
- body height · score 0.17
- monocyte percentage of leukocytes · score 0.16
- calcium measurement · score 0.14
- sitting height measurement · score 0.12
- platelet crit · score 0.11
- Male infertility with spermatogenesis disorder due to single gene mutation · score 0.09
- azoospermia · score 0.09
- Rare genetic female infertility · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-W5XKT8-F1 | alphafold | PREDICTED | 86.71 | — |
Amino-acid sequence (324 residues)
MALLALASAV PSALLALAVF RVPAWACLLC FTTYSERLRI CQMFVGMRSP KLEECEEAFT AAFQGLSDTE INYDERSHLH DTFTQMTHAL QELAAAQGSF EVAFPDAAEK MKKVITQLKE AQACIPPCGL QEFARRFLCS GCYSRVCDLP LDCPVQDVTV TRGDQAMFSC IVNFQLPKEE ITYSWKFAGG GLRTQDLSYF RDMPRAEGYL ARIRPAQLTH RGTFSCVIKQ DQRPLARLYF FLNVTGPPPR AETELQASFR EVLRWAPRDA ELIEPWRPSL GELLARPEAL TPSNLFLLAV LGALASASAT VLAWMFFRWY CSGN
Explore Sperm acrosome membrane-associated protein 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets